Immunocytochemistry as an Adjunct to Fine-needle Aspiration of Thyroid in Distinction Between Benign and Malignant Thyroid Neoplasms

Open access

Immunocytochemistry as an Adjunct to Fine-needle Aspiration of Thyroid in Distinction Between Benign and Malignant Thyroid Neoplasms

Introduction. Thyroid nodules are very common therefore distinction between benign and malignant tumors is essential for proper clinical management.

Aim of the study. The study was performed to evaluate the diagnostic value of molecular markers in different thyroid tumors.

Materials and methods. Forty-eight thyroid FNA cases confirmed by subsequent surgical resection specimens were selected. Immunocytochemistry for HBME-1, CD56 and E-cadherin (E-CAD) was performed. The study group consisted of 15 papillary thyroid cancers (PTC) and 1 follicular carcinoma (FC) as well as 12 follicular adenomas (FA) and 20 cases of colloid goiter (CG).

Results. The expression of HBME-1 in PTC was significantly higher than in another thyroid lesions. E-CAD and CD56 expression was found in 8/12 (66.6%) and 6/12 (50%) cases of FA respectively. In contrast, PTC showed very low expression (1/15) of both E-CAD and CD56. Expression of the three analyzed markers was not more than 10% in case of CG.

Conclusions. We concluded that immunocytochemical (ICC) staining is of value as an ancillary test to enhance the diagnostic accuracy of thyroid FNA biopsies. Larger studies dedicated to evaluate the role of these or other markers for distinction between FC and FA can be particularly useful. We recommend the small panel consisting of three ICC markers, HBME-1, E-CAD and CD56 as an adjunct to standard cytomorphology criteria to enhance the diagnostic accuracy of thyroid nodules with follicular-patterned cytologic features.

References
  • Baloch ZW, LiVolsi VA, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference // Diagn Cytopahol, 2008; 36(6): 425-437

  • Baloch ZW, LiVolsi VA. Fine-needle aspiration of the thyroid: today and tomorrow // Best Pract Res Clin Endocrinol Metab, 2008; 22(6):929-39

  • Baloch ZW, Fleisher S, et al. Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology // Diagn Cytopathol, 2002; 26(1):41-4

  • Brabant G, Hoang-Vu C, et al. E-cadherin: a differentiation marker in thyroid malignancies // Cancer Res, 1993; 53(20):4987-93

  • Choi YL, Kim MK, et al. Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas // J Korean Med Sci, 2005; 20(5):853-9

  • de Micco C, Savchenko V, et al. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV // Br J Cancer, 2008; 98(4):818-23

  • Eidelman S, Damsky CH, et al. Expression of the cell-cell adhesion glycoprotein cell-CAM 120/80 in normal human tissues and tumors // Am J Pathol, 1989; 135(1):101-10

  • El Demellawy D, Nasr A, Alowami S. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid // Pathol Res Pract, 2009; 30(1):78-83

  • El Demellawy D, Nasr A, Alowami S. Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid // Diagn Pathol, 2008; 3:5

  • Fadda G, Rossi ED, et al. Diagnostic efficacy of immunocytochemistry on fine needle aspiration biopsies processed by thin-layer cytology // Acta Cytol, 2006; 50(2):129-35

  • Finley DJ, Arora N, et al. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules // J Clin Endocrinol Metab, 2004; 89(7):3214-23

  • Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment // Endocrinol Metab Clin North Am, 2007; 36(3): 707-35

  • Gharib H, Papini E, et al. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations // J Endocrinol Invest, 2010; 33(5):51-6

  • Graff JR, Greenberg VE, et al. Distinct patterns of E-cadherin CpG island methylation in papillary, follicular, Hurthle's cell, and poorly differentiated human thyroid carcinoma // Cancer Res, 1998; 58(10):2063-6

  • Greig ED, Gray AC. Note on the Lymphatic Glands in Sleeping Sickness // Br Med J, 1904; 1(2265):1252

  • Gul K, Ersoy R, et al. Ultrasonographic evaluation of thyroid nodules: comparison of ultrasonographic, cytological, and histopathological findings // Endocrine, 2009; 36(3):464-72

  • Haugen BR, Woodmansee WW, McDermott MT. Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumors // Clin Endocrinol (Oxf), 2002; 56(3):281-90

  • Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis // Cancer Sci, 2003; 94(7):575-81

  • Hundahl SA, Cady B, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U. S., 1985-1995 // Cancer, 1998; 83(12):2638-48

  • Ito Y, Yoshida H, et al. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma // Anticancer Res, 2005; 25(1A):179-82

  • Yoon JH, Kwak JY, et al. How to approach thyroid nodules with indeterminate cytology // Ann Surg Oncol, 2010; 17(8):2147-55

  • Kesmodel SB, Terhune KP, et al. The diagnostic dilemma of follicular variant of papillary thyroid carcinoma // Surgery, 2003; 134(6):1005-12

  • Lee YH, Kim BH, et al. Comparison of cytological results obtained by repeated US-guided fine-needle aspiration biopsies of thyroid nodules: focus on the rate of malignancy and diagnostic concordance // Diagn Cytopathol, 2009; 37(7):492-7

  • Lundgren CI, Zedenius J, Skoog L. Fine-needle aspiration biopsy of benign thyroid nodules: an evidence-based review // World J Surg, 2008; 32(7):1247-52

  • Mazzaferri EL. Management of a solitary thyroid nodule // N Engl J Med, 1993; 328(8):553-9

  • Nasr MR, Mukhopadhyay S, et al. Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: Utility of HBME1 combined with CK19 immunostaining // Mod Pathol, 2006; 19(12):1631-7

  • Nga ME, Lim GS, et al. HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma // Diagn Cytopathol, 2008; 36(8):550-6

  • Nguyen GK, Lee MW, et al. Fine-needle aspiration of the thyroid: an overview // Cytojournal, 2005; 2(1):12

  • Ogilvie JB, Piatigorsky EJ, Clark OH. Current status of fine needle aspiration for thyroid nodules // Adv Surg, 2006; 40:223-38

  • Ozolins A, Narbuts Z, et al. Diagnostic utility of immunohistochemical panel in various thyroid pathologies // Langenbecks Arch Surg, 2010; 395(7):885-91

  • Redman R, Zalaznick H, et al. The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules // Thyroid, 2006; 16(1):55-60

  • Rossi ED, Raffaelli M, et al. Immunocytochemical evaluation of thyroid neoplasms on thin-layer smears from fine-needle aspiration biopsies // Cancer, 2005; 105(2):87-95

  • Saleh HA, Freng J, et al. Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy // Cytojournal, 2009; 6:18

  • Saleh HA, Jin B, et al. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules // Diagn Pathol, 2010; 5:9

  • Scarpino, S., et al., Papillary carcinoma of the thyroid: low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells. J Pathol, 2007. 212(4): p. 411-9.

  • Shih SR, Di Napoli A, et al. Follicular variant of papillary thyroid carcinoma: diagnostic limitations of fine needle aspiration cytology // Acta Cytol, 2005; 49(4):383-6

  • Soares P, Berx G, et al. E-cadherin gene alterations are rare events in thyroid tumors // Int J Cancer, 1997; 70(1):32-8

  • Topliss D. Thyroid incidentaloma: the ignorant in pursuit of the impalpable // Clin Endocrinol (Oxf), 2004; 60(1):18-20

  • Werga P, Wallin G, et al. Expanding role of fine-needle aspiration cytology in thyroid diagnosis and management // World J Surg, 2000; 24(8):907-12

  • Wu M, Burstein DE, et al. A comparative study of 200 fine needle aspiration biopsies performed by clinicians and cytopathologists // Laryngoscope, 2006; 116(7):1212-5

  • Wu HH, Jones JN, Osman J. Fine-needle aspiration cytology of the thyroid: ten years experience in a community teaching hospital // Diagn Cytopathol, 2006; 34(2):93-6

  • Zeromski J, Bagnasco M, et al. Expression of CD56 (NKH-1) differentiation antigen in human thyroid epithelium // Clin Exp Immunol, 1992; 89(3): 474-8

Acta Chirurgica Latviensis

The Journal of Riga Stradins University; Latvian Association of Surgeons; Latvian Association of Paediatric Surgeons

Journal Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 9 9 9
PDF Downloads 2 2 2